Featured Review: Evidence for the benefits and harms of screening for malignant melanoma
The Cochrane Review Screening for reducing morbidity and mortality in malignant melanoma has been recently updated. Below is an interview with the Director of Cochrane Nordic and author of the review, Karsten Juhl Jørgensen to learn what the latest evidence says and why it is important.